Imaging biomarkers have emerged as increasingly important endpoints in cancer clinical trials. Incorporating tumor metric reads as part of routine clinical reads by on-site radiologists for cancer clinical trials has several challenges which can be a... read more
OBJECTIVES: To develop and validate machine learning (ML) models using clinical and contrast-enhanced CT (CECT) parameters to assess recurrence risk in hepatocellular carcinoma (HCC) after transarterial chemoembolization (TACE) achieving imaging comp... read more
PURPOSE: As artificial intelligence (AI) models evolve into their next generations, their application in specialized medical fields requires rigorous validation. While large language models (LLMs) have shown promise in general medicine, their reliabi... read more
Join thousands of healthcare professionals staying informed about the latest AI breakthroughs in medicine. Get curated insights delivered to your inbox.